The metabolic syndrome and CVD outcomes for a central Australian cohort

详细信息    查看全文

• 作者：Joanne N. Luke^a ; ^{jnluke@unimelb.edu.au} ; Alex Brown^b ; ^c ; ^{alex.brown@sahmri.com} ; Mark Daniel^d ; ^e ; ^{mark.daniel@unisa.edu.au} ; Kerin O&rsquo ; Dea^f ; ^{ko@unimelb.edu.au} ; James D. Best^g ; ^{jdbest@unimelb.edu.au} ; Alicia J. Jenkins^e ; ^{jenkinsa@medstv.unimelb.edu.au} ; Zhiqiang Wang^h ; ^{z.wang@uq.edu.au} ; Robyn A. McDermottⁱ ; ^{robyn.mcdermott@unisa.edu.au} ; Zaimin Wang^h ; ^{z.wang2@uq.edu.au} ; Kevin G. Rowley^a ; ^{rowleyk@unimelb.edu.au}
• 关键词：Aboriginal ; Indigenous ; Metabolic syndrome ; Cardiovascular disease
• 刊名：Diabetes Research and Clinical Practice
• 出版年：2013
• 出版时间：June, 2013
• 年：2013
• 卷：100
• 期：3
• 页码：e70-e73
• 全文大小：301 K

文摘

We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascular disease (CVD) for Aboriginal people from central Australia. WHO (HR 2.83), NCEP (1.80) and IDF (2.47) definitions of the MetS all had positive associations with CVD, however offered little above individual MetS components for hyperglycaemia.